Jaguar Health
JAGX
10 hedge funds and large institutions have $61.4K invested in Jaguar Health in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 5 → 10 (+5)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.08% less ownership
Funds ownership: 0.14% → 0.06% (-0.08%)
72% less capital invested
Capital invested by funds: $223K → $61.4K (-$162K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.9K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$20.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$360 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$51 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$118K |
| 2 |
Morgan Stanley
New York
|
-$23 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $22.4K | +$38.9K | +756 | New |
|
|
DS
2
DRW Securities
Chicago,
Illinois
| $16.6K | -$118K | -2,299 | -80% |
|
|
XT
3
XTX Topco
George Town,
Cayman Islands
| $11.6K | +$20.1K | +391 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $5.95K | +$10.3K | +201 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3.36K | +$360 | +7 | +7% |
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $205 | – | – | – |
|
|
LSA
8
Leonteq Securities AG
Zurich,
Switzerland
| $175 | – | – | – |
|
|
IAIM
9
International Assets Investment Management
Orlando,
Florida
| $42 | +$51 | +1 | New |
|
|
10
Bank of America
Charlotte,
North Carolina
| $28 | +$51 | +1 | New |
|
11
BlackRock
New York
| $4 | – | – | – |
|
|
12
Morgan Stanley
New York
| – | -$23 | – | – |
|
JAGX Hedge Fund Activity: Q4 2025 in Review
10 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Jaguar Health (JAGX) for Q4 2025, worth a combined $61.4K — down 72% from $223K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new JAGX positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $38.9K. The largest seller was DRW Securities, cutting an estimated $118K.
- 10 institutional investors held Jaguar Health (JAGX) as of Q4 2025, up from 5 in Q3 2025.
- Funds reported $61.4K of Jaguar Health stock for Q4 2025, down 72% quarter-over-quarter.
- 5 funds opened new Jaguar Health positions in Q4 2025 and 0 closed out, a net change of +5 holders.
- The largest Jaguar Health buyer in Q4 2025 was Geode Capital Management, an estimated $38.9K added.
- The largest Jaguar Health seller in Q4 2025 was DRW Securities, an estimated $118K sold.
Based on aggregated 13F filings for Q4 2025.